Radiation-induced angiosarcoma (RIAS) of the breast is a rare and aggressive malignancy that emerges as a late complication of radiation therapy for primary breast cancer. We present the case of a 56-year-old woman with a history of high-grade ductal carcinoma in situ (DCIS) of the breast, previously treated with lumpectomy, sentinel lymph node biopsy, radiation therapy, and anastrozole. Five years after treatment, she developed new skin changes on her breast, including bruising and blistering following tanning bed use. Imaging studies showed diffuse skin thickening without discrete masses or lymphadenopathy. Biopsies confirmed the diagnosis of angiosarcoma. An extended mastectomy with wide surgical margins was performed. Pathological examination confirmed angiosarcoma with negative margins and no lymph node involvement. Additional excisions were undertaken to achieve 3 cm gross margins to ensure complete tumor removal due to the aggressive nature of the tumor. Patients presenting with new skin changes in previously irradiated areas, even many years after treatment, require careful evaluation. Nonspecific clinical and imaging findings necessitate prompt biopsy for accurate diagnosis. Surgical excision with wide margins remains the primary treatment modality, but standardized guidelines are lacking due to the rarity of RIAS. A multidisciplinary approach involving surgical oncology, pathology, radiology, and reconstructive surgery is essential for optimal patient management. Educating patients about potential late complications of radiation therapy and advising against additional risk factors, such as ultraviolet 2 exposure from tanning beds, are important. Further research is needed to establish evidence-based guidelines for the diagnosis, treatment, and follow-up of RIAS.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11849759 | PMC |
http://dx.doi.org/10.7759/cureus.77954 | DOI Listing |
ChemMedChem
March 2025
University of Windsor, Chemistry and Biochemistry, 401 Sunset Ave., N9B 3P4, Windsor, CANADA.
Boron Neutron Capture Therapy (BNCT) leverages the nuclear reaction between boron-10 and thermal neutrons to selectively destroy cancer cells while minimizing damage to surrounding healthy tissues. This therapy has found use in treating glioblastoma, which as a brain cancer, is difficult to treat using conventional radiotherapy, surgery, and chemotherapy due to location and the risk of brain damage. However, to work, the cells must contain 10B.
View Article and Find Full Text PDFBull Cancer
March 2025
Dermatologie, CHU de Tours, Tours, France; Réseau CARADERM, France.
Merkel cell carcinoma (MCC) is a rare skin cancer that mainly affects the elderly, and whose incidence is increasing. Although the exact origin of this cancer remains uncertain, research in recent years has revealed that MCC develops through two oncogenesis pathways: virally induced by the Merkel polyomavirus (80% of cases) and induced by mutations linked to ultraviolet rays (20% of cases). MCC is an aggressive cancer, with a high mortality rate and limited therapeutic options in advanced stage.
View Article and Find Full Text PDFBull Cancer
March 2025
Pediatric Oncology, insitut Gustave-Roussy, Villejuif, France. Electronic address:
Amongst Ewing sarcoma family of tumours, (EFST), cutaneous/subcutaneous Ewing sarcoma are defined as tumours arising from cutaneous or subcutaneous tissue, not invading the underlying aponeurosis. They are rare tumours, with less than 200 patients published. They are typically small tumours (less than 5cm), and can arise at any anatomical location, with a particular tropism for distal, truncal and head/neck locations, compared to classical Ewing sarcoma.
View Article and Find Full Text PDFBull Cancer
March 2025
Oncologie médicale, Institut Curie, Paris, France.
Patients who develop Ewing sarcoma with extra-pulmonary metastasis have a poor prognosis. A recent French protocol, CombinaiR3, was set up to evaluate the efficacy of induction chemotherapy followed by high-dose chemotherapy and metronomic maintenance treatment. It is now closed for inclusions and while waiting for the results, we propose a French consensus guideline for the management of patients diagnosed with Ewing sarcoma with extra-pulmonary dissemination.
View Article and Find Full Text PDFBest Pract Res Clin Haematol
December 2024
Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, SW7 2AZ, UK.
Radiological accidents/incidents are common with nearly 400 reported since 1944 exposing about 3000 people to substantial doses of ionizing radiations with 127 deaths. Damage to hematopoietic stem and progenitor cells with resulting bone marrow failure is a common consequence of exposure to whole body acute high-dose and -dose-rate ionizing radiations and is termed hematopoietic-acute radiation syndrome, or H-ARS. Therapy of H-ARS includes transfusions, anti-bacterial and -viral drugs, molecularly-cloned hematopoietic growth factors and hematopoietic cell transplants.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!